Back to NRIX
Vestal Point Capital, LP → NRIX
Vestal Point Capital, LP NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
4
Latest value
$166.6M
Q3 2026
Peak value
$195.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $89M |
| Q1 2026 | $100.8M |
| Q2 2026 | $195.3M |
| Q3 2026 | $166.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $166.6M | 7.03M | — | — |
| Q2 2026 | $195.3M | 8.05M | — | — |
| Q1 2026 | $100.8M | 6.50M | — | — |
| Q4 2025 | $89M | 4.69M | — | — |
Other funds holding NRIX
$187.7M
$187.3M
$175.3M
$164.8M
$153.5M
$142.3M
$133.5M